{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:50:35Z","timestamp":1785887435375,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005066","name":"Key Medical Subjects of Jiangsu Province","doi-asserted-by":"publisher","award":["YXZXA2016002"],"award-info":[{"award-number":["YXZXA2016002"]}],"id":[{"id":"10.13039\/501100005066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX09304021"],"award-info":[{"award-number":["2017ZX09304021"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020770","name":"Young Medical Key Talents Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["JCRCA2016002"],"award-info":[{"award-number":["JCRCA2016002"]}],"id":[{"id":"10.13039\/501100020770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC0840604"],"award-info":[{"award-number":["2019YFC0840604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0104502"],"award-info":[{"award-number":["2017YFA0104502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20211070"],"award-info":[{"award-number":["BK20211070"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015798","name":"Suzhou Key Medical Center","doi-asserted-by":"publisher","award":["LCZX202101"],"award-info":[{"award-number":["LCZX202101"]}],"id":[{"id":"10.13039\/100015798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.transproceed.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:54:11Z","timestamp":1781038451000},"page":"1185-1194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced Dose of Pre-Transplant Cyclophosphamide in Bu\/Cy Conditioning Regimens Promote the Prognosis of Patients With Younger Donors in Haploidentical Hematopoietic Stem Cell Transplantation for Aplastic Anemia"],"prefix":"10.1016","volume":"58","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiya","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3894-0631","authenticated-orcid":false,"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.transproceed.2026.05.013_bib0001","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.17403","article-title":"Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries","volume":"194","author":"Scheinberg","year":"2021","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.transproceed.2026.05.013_bib0002","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100772","article-title":"Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies","volume":"47","author":"Iftikhar","year":"2021","journal-title":"Blood Rev"},{"issue":"12","key":"10.1016\/j.transproceed.2026.05.013_bib0004","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1038\/s41375-020-0933-7","article-title":"Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia","volume":"34","author":"Liu","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.transproceed.2026.05.013_bib0005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jpeds.2008.06.004","article-title":"Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine","volume":"153","author":"Scheinberg","year":"2008","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.transproceed.2026.05.013_bib0006","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41409-020-01169-7","article-title":"Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges","volume":"56","author":"Xu","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.013_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","article-title":"Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant","volume":"10","author":"Xu","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.013_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajh.25693","article-title":"Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: a KSGCT prospective study","volume":"95","author":"Kako","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.013_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","article-title":"The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology","volume":"11","author":"Xu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0010","first-page":"2195","article-title":"Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion","volume":"30","author":"Storb","year":"1970","journal-title":"Cancer Res"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1002959","article-title":"Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation","volume":"13","author":"Mu\u00f1iz","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.013_bib0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/bbmt.2001.v7.pm11215697","article-title":"Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers","volume":"7","author":"Storb","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.transproceed.2026.05.013_bib0013","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41409-019-0509-1","article-title":"Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation","volume":"54","author":"Xu","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.013_bib0014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00277-020-04312-y","article-title":"Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial","volume":"100","author":"Seydoux","year":"2021","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.transproceed.2026.05.013_bib0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/clpt.2009.27","article-title":"Personalized dosing of cyclophosphamide in the total body irradiation\u2013cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy","volume":"85","author":"McCune","year":"2009","journal-title":"Clin Pharmacol amp; Therap"},{"issue":"9","key":"10.1016\/j.transproceed.2026.05.013_bib0016","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2352-3026(15)00147-7","article-title":"Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study","volume":"2","author":"Anderlini","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.01203","article-title":"Secondary neoplasms after hematopoietic cell transplant for sickle cell disease","author":"Eapen","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0018","article-title":"A modified conditioning regimen based on low-dose cyclophosphamide and fludarabine for haploidentical hematopoietic stem cell transplant in severe aplastic anemia patients at risk of severe cardiotoxicity","author":"Lin","year":"2021","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.05.013_bib0019","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","article-title":"Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide","volume":"5","author":"Dezern","year":"2021","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.transproceed.2026.05.013_bib0020","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.bbmt.2016.09.012","article-title":"Effect of recipient age and stem cell source on the association between donor telomere length and survival after allogeneic unrelated hematopoietic cell transplantation for severe aplastic anemia","volume":"22","author":"Gadalla","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.transproceed.2026.05.013_bib0021","volume":"13","author":"Li","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.967026","article-title":"The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: a real-world study","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.transproceed.2026.05.013_bib0023","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41409-020-0897-2","volume":"55","author":"ElGohary","year":"2020","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1016\/j.transproceed.2026.05.013_bib0024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbmt.2008.12.489","article-title":"Busulfan in hematopoietic stem cell transplantation","volume":"15","author":"Ciurea","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.transproceed.2026.05.013_bib0025","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/cix690","article-title":"Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey","volume":"65","author":"Girmenia","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"29","key":"10.1016\/j.transproceed.2026.05.013_bib0026","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.transproceed.2026.05.013_bib0027","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/stcltm\/szac015","article-title":"Current status and perspectives of allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia","volume":"11","author":"Sophie","year":"2022","journal-title":"Stem Cells Translat Med"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.013_bib0028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.013_bib0029","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41409-020-01065-0","article-title":"Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation","volume":"56","author":"Sugita","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.transproceed.2026.05.013_bib0030","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.bmt.1702707","article-title":"Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood","volume":"26","author":"Kato","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2026.05.013_bib0031","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","article-title":"Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transproceed.2026.05.013_bib0032","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1182\/blood.V98.12.3456","article-title":"Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide","volume":"98","author":"Luznik","year":"2001","journal-title":"Blood"},{"issue":"211","key":"10.1016\/j.transproceed.2026.05.013_bib0033","doi-asserted-by":"crossref","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Translat Med"},{"issue":"6","key":"10.1016\/j.transproceed.2026.05.013_bib0034","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.transproceed.2026.05.013_bib0035","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bmt.1705165","article-title":"Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party","volume":"36","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2026.05.013_bib0036","article-title":"Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults","author":"Holtick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0037","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.013_bib0038","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-6143.2011.03798.x","article-title":"Donor age-specific injury and immune responses","volume":"12","author":"Oberhuber","year":"2012","journal-title":"Am J Transplant"},{"issue":"7513","key":"10.1016\/j.transproceed.2026.05.013_bib0039","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature13619","article-title":"Replication stress is a potent driver of functional decline in ageing hematopoietic stem cells","volume":"512","author":"Flach","year":"2014","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.transproceed.2026.05.013_bib0040","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/bloodadvances.2020001620","article-title":"Impact of donor age and kinship on clinical outcomes after T-cell\u2013replete haploidentical transplantation with PT-Cy","volume":"4","author":"Mariotti","year":"2020","journal-title":"Blood Advances"},{"issue":"5","key":"10.1016\/j.transproceed.2026.05.013_bib0041","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","article-title":"Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide","volume":"5","author":"Dezern","year":"2021","journal-title":"Blood Advances"},{"issue":"2","key":"10.1016\/j.transproceed.2026.05.013_bib0042","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.transproceed.2026.05.013_bib0043","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transproceed.2026.05.013_bib0044","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2026.05.013_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamaoncol.2021.6846","article-title":"Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors","volume":"8","author":"Guru Murthy","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.05.013_bib0046","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/bbmt.2001.v7.pm11215697","article-title":"Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers","volume":"7","author":"Storb","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2026.05.013_bib0047","article-title":"Who is a better donor for recipients of allogeneic hematopoietic cell transplantation: a young HLA-mismatched haploidenitcal relative or an older fully HLAmatched sibling or unrelated donor?","author":"Eva Karam","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526002678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526002678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:19:56Z","timestamp":1785885596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526002678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0041134526002678"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.05.013","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced Dose of Pre-Transplant Cyclophosphamide in Bu\/Cy Conditioning Regimens Promote the Prognosis of Patients With Younger Donors in Haploidentical Hematopoietic Stem Cell Transplantation for Aplastic Anemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}